Day 3 Program

Educational Session 11: How to Treat TNBC—Triple-Negative Not so Negative Anymore

Day 3: December 11, 2025

2:30 PM–4:15 PM CST

Stars at Night 1-2

Session Details

The session discussed treatment escalation and de-escalation for stage I TNBC, tailored strategies for stage II and III disease, and the latest advances in managing metastatic TNBC.

ED11-01

To escalate or de-escalate treatment for Stage 1 TNBC

Gustavo Werutsky, LACOG Cancer Research Network, Sao Paulo, Brazil

ED11-02

Tailored therapy for stage II and III TNBC

Elie Rassy, Cleveland Clinic, Cleveland, OH

ED11-03

Treatment updates in metastatic TNBC

Sara Tolaney, Dana-Farber Cancer Institute, Boston, MA

Advocate

Janice Cowden, PCDI, Bradenton, FL